- Advertisement -
SOUTH SAN FRANCISCO, Calif., & PRINCETON, N.J.–(BUSINESS WIRE)– #ACC26–Kardigan announced results from KARDINAL, a Phase 2 clinical trial evaluating the effects of tonlamarsen in patients with uncontrolled hypertension.
Click here to view the original article.

